Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Apr;39(4):463-470.
doi: 10.14670/HH-18-637. Epub 2023 Jun 6.

Targeting eIF5A2 reduces invasion and reverses chemoresistance in SCC-9 cells in vitro

Jinbo Gao  1 , Peng Li  2
Affiliations

Targeting eIF5A2 reduces invasion and reverses chemoresistance in SCC-9 cells in vitro

Jinbo Gao et al. Histol Histopathol. 2024 Apr.

Abstract

Background and aims: Eukaryotic translation initiation factor 5A2 (EIF5A2) has been reported to be involved in metastasis and chemotherapy resistance in many human cancers. However, the effect and mechanism of EIF5A2 in oral cancer cells are unknown. Here, we investigated the effects of targeting EIF5A2 on chemotherapy resistance in oral cancer cells in vitro.

Methods: By using a lentiviral system, we investigated the effects of targeting EIF5A2 on the invasion, migration, growth, and chemosensitivity of SCC-9 cells to CDDP in vitro. Through the method of gene intervention, we explore the role of pro-apoptotic Bim and epithelial and mesenchymal marker E-cadherin protein in this process and the regulation of EIF5A2 on Bim and E-cadherin.

Results: Targeting EIF5A2 reduces invasion and migration in SCC-9 cells partly through upregulation of E-cadherin expression; Targeting EIF5A2 promotes cell apoptosis and inhibits cell survival as well as increasing chemosensitivity in SCC-9 cells through upregulation of Bim expression.

Conclusion: EIF5A2 may be a novel potential therapeutic target for oral cancer by upregulation of Bim and E-cadherin.

PubMed Disclaimer

References

    1. Al-Othman M.O., Morris C.G., Hinerman R.W., Amdur R.J. and Mendenhall W.M. (2003). Distant metastases after definitive radiotherapy for squamous cell carcinoma of the head and neck. Head Neck 25, 629-633. - PubMed
    1. Bao Y., Zhang Y., Lu Y., Guo H., Dong Z., Chen Q., Zhang X., Shen W., Chen W. and Wang X. (2020). Overexpression of microRNA-9 enhances cisplatin sensitivity in hepatocellular carcinoma by regulating EIF5A2-mediated epithelial-mesenchymal transition. Int. J. Biol. Sci. 16, 827-837. - PMC - PubMed
    1. Bhola P.D. and Letai A. (2016). Mitochondria-judges and executioners of cell death sentences. Mol. Cell 61, 695-704. - PMC - PubMed
    1. Chen Z., Yu T., Zhou B., Wei J., Fang Y., Lu J., Guo L., Chen W., Liu Z.P. and Luo J. (2016). Mg(II)-catechin nanoparticles delivering siRNA targeting EIF5A2 inhibit bladder cancer cell growth in vitro and in vivo. Biomaterials 81, 125-134. - PubMed
    1. Chi A.C., Day T.A. and Neville B.W. (2015). Oral cavity and oropharyngeal squamous cell carcinoma: an update. CA Cancer J. Clin. 65, 401-421. - PubMed